Skip to content

Effects of the Family Resilience Enhancement Program for Families of Patients with Breast Cancer: A Feasible Study

Effects of the Family Resilience Enhancement Program for Families of Patients with Breast Cancer: A Feasible Study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052108
Enrollment
Unknown
Registered
2021-10-17
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

control group:Conventional nursing
Experimental group:Family resilience intervention

Sponsors

School of Nursing, Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patient: 1. Female patients with first pathological diagnosis of breast cancer; 2. Aged 18 years and above; 3. Patients undergoing surgical treatment; 4. Good understanding and communication skills, no history of mental illness; 5. Informed consent, willing to cooperate. Dependents: 1. The primary caregiver of the patient; 2. Aged 18 years and above; 3. Good understanding and communication skills, no history of mental illness; 4. Informed consent, willing to cooperate.

Exclusion criteria

Exclusion criteria: 1. Those with other serious diseases; 2. Patients who participate in other psychological interventions; 3. Consciousness, understanding and communication barriers.

Design outcomes

Primary

MeasureTime frame
Family Resilience Assessment;

Secondary

MeasureTime frame
Coping Style Questionnaire;Family burden scale of disease;Social support scale;

Countries

China

Contacts

Public ContactLi Huiping

School of Nursing, Anhui Medical University

hulihuizi@163.com+86 13956993566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 26, 2026